Anticoagulation Strategies in the Perioperative Period for Lung Transplant.
Where this comes from
- Record sourced from PubMed, PMID 31981503.
- Also identified by DOI 10.1016/j.athoracsur.2019.11.056.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patients who are undergoing lung transplantation may require systemic anticoagulation in the perioperative period for various indications at the time of the procedure. Four-factor prothrombin complex concentrate has been approved in the United States to reverse the effects of warfarin for patients requiring urgent surgery. We describe a perioperative anticoagulation strategy with warfarin that is reversed before incision using 4-factor complex concentrate for off-pump lung transplant recipients.
Medical subject headings
- Blood Coagulation Factors
- Lung Transplantation
- Perioperative Care
- Thrombosis
- Transplant Recipients
- Warfarin